Products

Wereader

RSS reader with extra tools for heavy readers and publishers.

wereader.app Entertainment & Media / Books & Reading

AI Benchmark
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Free
No monthly subscription pricing
Creators
Airy Li
@iamairyland· 2,841 followers
Launched
8y ago
2018-09-14 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on V2EX (51 comments)Launch

    我们做了个阅读器 WeReader,不只于支持 RSS — WeReader 介绍 我们开发了一个阅读器 WeReader。虽然核心功能是 RSS,但是我们做了 RSS 协议之外的功能补充,希望它可以成为重度资讯阅读用户或者自媒体运营者的阅读和资讯管理中心,能帮助用户提高效率、节省时间、快速获取素材和灵感。 全屏阅读模式 作为一个阅读…

    Sep 14, 2018 · 8y agoLaunch page

Third-party reviews & case dossiers

Acquisition breakdowns, engineer reviews & open-source metrics
V2EX
2018-09-14Source

Traffic sources

Oct 2026

Traffic breakdown

Channels

  • Direct29%
  • Organic Search25%
  • Referrals12%
  • Display Ads10%
  • Other24%

Countries

No data yet

Search

Domain authority —Domain registered 2025-02-21

KeywordMonthly volume
reader app1,440

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2026-07-31

Key pages

Weekly snapshots

No page snapshots yet. Once followed, home and pricing pages are captured weekly.

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does Wereader get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Wereader and what platforms does it support?
Wereader is catalogued under Books & Reading: RSS reader with extra tools for heavy readers and publishers. Supported platforms: Web.

Related products in this category

Entertainment & Media / Books & Reading

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.